ir.cytomx.com ir.cytomx.com

ir.cytomx.com

Investors - Investors & News - CytomX

160; 0.13. 01/10/17 2:00 pm PT. CytomX Therapeutics Inc at 35th Annual JP Morgan Healthcare Conference. CTMX Corporate Presentation January 2017. January 09, 2017. UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference. January 09, 2017. CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference. December 14, 2016. Data provided by Nasdaq. Minimum 15 minutes delayed.

http://ir.cytomx.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.CYTOMX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 2.2 out of 5 with 5 reviews
5 star
0
4 star
0
3 star
3
2 star
0
1 star
2

Hey there! Start your review of ir.cytomx.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.7 seconds

CONTACTS AT IR.CYTOMX.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investors - Investors & News - CytomX | ir.cytomx.com Reviews
<META>
DESCRIPTION
160; 0.13. 01/10/17 2:00 pm PT. CytomX Therapeutics Inc at 35th Annual JP Morgan Healthcare Conference. CTMX Corporate Presentation January 2017. January 09, 2017. UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference. January 09, 2017. CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference. December 14, 2016. Data provided by Nasdaq. Minimum 15 minutes delayed.
<META>
KEYWORDS
1 management team
2 scientific advisory board
3 board of directors
4 our approach
5 probody therapeutics
6 publications
7 pipeline
8 partners
9 investors and news
10 news and events
CONTENT
Page content here
KEYWORDS ON
PAGE
management team,scientific advisory board,board of directors,our approach,probody therapeutics,publications,pipeline,partners,investors and news,news and events,corporate governance,financials and filings,investor resources,careers,you are here,print page
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investors - Investors & News - CytomX | ir.cytomx.com Reviews

https://ir.cytomx.com

160; 0.13. 01/10/17 2:00 pm PT. CytomX Therapeutics Inc at 35th Annual JP Morgan Healthcare Conference. CTMX Corporate Presentation January 2017. January 09, 2017. UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference. January 09, 2017. CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference. December 14, 2016. Data provided by Nasdaq. Minimum 15 minutes delayed.

OTHER SITES

ir.cybergypartners.com ir.cybergypartners.com

Cybergy Holdings, Inc. (CYBG)

Cybergy Holdings, Inc. (OTCPink: CYBG). Our Services and Products. Commercial and Government Clients. Bill Gregorak Appointed New Chief Financial Officer of Cybergy Partners. Aug 5, 2015. Mar 31, 2015. Sign up for email alerts. Be the first to receive breaking news. Chairman, Cybergy Board of Directors / CEO. Mr Gray is Chairman of the Cybergy Partners Board of Directors, leading its acquisition strategy and investment committee. He has over 20 years of M&A, investment banking and financial advisory ...

ir.cyberonics.com ir.cyberonics.com

Investor Relations | Cyberonics

Skip to main content. An innovator in neuromodulation. Learn about Cyberonics, the creator of VNS Therapy. An innovator in neuromodulation. Discover more about Cyberonics innovation. Committed to advancing science. Apply for grants for CME credit, physician and patient educational programs, and more. Search career opportunities at Cyberonics. Table of content - -. Day High: 59.26. Day Low: 57.90. Aug 7, 2015. Delayed at least 20 min., by eSignal. View all ». Aug 6, 2015. Jul 27, 2015. View all ». Cyberon...

ir.cymabay.com ir.cymabay.com

CYMABAY THERAPEUTICS

CymaBay Therapeutics (NASDAQ: CBAY). CymaBay Therapeutics is a clinical-stage biopharmaceutical company developing breakthrough therapies addressing unmet medical needs. Arhalofenate, the company's lead product candidate, possesses two therapeutic actions in a single drug. In gout patients, arhalofenate is intended to prevent painful attacks in joints while at the same time promoting excretion of uric acid by the kidney, thereby removing the root cause of this debilitating disease. As of March 3, 2014).

ir.cyren.com ir.cyren.com

Investor Relations - CYREN

Solutions for Resellers and Distributors. Solutions for Service Providers. Solutions for Security Vendors. Mobile Security for Android. Industry Reports and White Papers. Annual Reports and Proxies. CYREN is traded on the NASDAQ Capital Market and the Tel Aviv Stock Exchange (TASE) under the trading symbol “CYRN”. NASDAQ and TASE: CYRN. 4:00 PM ET on August 14, 2015. Delayed at least 20 minutes. August 12, 2015. CYREN Announces Pricing Of Public Offering Of Ordinary Shares. August 11, 2015.

ir.cytokinetics.com ir.cytokinetics.com

Cytokinetics - Investors & Media - Investor Overview

We’re dedicated to the research and development of therapies for people suffering from debilitating diseases that rob them of key muscle functions. We’re dedicated to the research and development of therapies for people suffering from debilitating diseases that rob them of key muscle functions. We’re advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue. Cytokinetics’ unparalleled expertise has kept it at the forefront of drug d...

ir.cytomx.com ir.cytomx.com

Investors - Investors & News - CytomX

160; 0.13. 01/10/17 2:00 pm PT. CytomX Therapeutics Inc at 35th Annual JP Morgan Healthcare Conference. CTMX Corporate Presentation January 2017. January 09, 2017. UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference. January 09, 2017. CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference. December 14, 2016. Data provided by Nasdaq. Minimum 15 minutes delayed.

ir.cytori.com ir.cytori.com

Cytori - Investor Relations

Meeting and Proxy Materials. Powered By Q4 Inc. April 10, 2018. April 24, 2018. June 4, 2018. October 9, 2018. Stock Quotes and Chart. Mar 29, 2018 04:00 PM. Pricing delayed 20 minutes. On May 10, 2016 the Company effected a 1:15 reverse stock split. Maxim Group, LLC. Joseph Pantginis, Ph.D. Henry W. McCusker. Stephen G. Brozak. WBB Securities, LLC. Shareholder correspondence should be mailed to:. College Station, TX 77842-3170. Overnight correspondence should be sent to:. 211 Quality Circle, Suite 210.

ir.cyxyz.cn ir.cyxyz.cn

cyxyz.cn

ir.d7do2c93.win ir.d7do2c93.win

灰指甲能穿襪子,灰指甲能治療好嗎,灰指甲治療,灰指甲治療新藥 樂指利價錢,灰指甲治療方法,灰指甲治療新藥價格,灰指甲治療秘方

Loceryl nail lacquer 樂指利抗甲癬油劑. Mega shop 美國varisi 指甲美化液. 灰指甲能穿襪子,灰指甲能治療好嗎,灰指甲治療,灰指甲治療新藥 樂指利價錢,灰指甲治療方法,灰指甲治療新藥價格,灰指甲治療秘方.

ir.datadomain.com ir.datadomain.com

Company Overview | Data Domain | Investor Overview

Data Domain deduplication storage systems dramatically reduce the amount of disk storage needed to retain and protect enterprise data. Fast, inline deduplication for the data center. Up to 1.4 TB/hour of aggregate throughput. Up to 1.7 PB of deduplication storage. Data Domain deduplication storage systems dramatically reduce the amount of disk storage needed to retain and protect enterprise data. Symantec NetBackup Best Practices. Data Center and Green IT. Midrange and Mainframe Systems. Answers to the m...

ir.datalinks.co.jp ir.datalinks.co.jp

投資家情報 | データリンクス株式会社

IRトップ. 12491;ュース&トピックス. IRニュース. 32076;営方針. 26989;績・財務. IR資料室. IRスケジュール. 26666;式情報. 38651;子公告. IRよくあるご質問.